Kynam Capital Management, LP

PRINCETON, NJ · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$1.81B2026 Q3
Positions34
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.72.3%

Kynam Capital Management, LP reported 34 positions worth $1.81B as of September 30, 2026 (13F filed November 16, 2026). Largest holding: LEGN (10.1%). Biggest move: add LEGN ($122.4M).

10 / 34 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 LEGNLegend Biotech$182.1M10.08%9,154,389——-12.0%
▸ 2 CLDXCelldex Therapeutics$164.2M9.09%5,066,051———
▸ 3 SNDXSyndax Pharmaceuticals$153.2M8.48%8,150,959——-49.7%
▸ 4 PCVXVaxcyte$148.4M8.22%2,607,964——+8.3%
▸ 5 VRDNViridian Therapeutics$126.6M7.01%6,148,000——+49.9%
▸ 6 COGTCogent Biosciences$121.4M6.72%3,792,289——-10.8%
▸ 7 TVTXTravere Therapeutics$117.8M6.52%2,000,000——-15.6%
▸ 8 URGNUroGen Pharma$98.9M5.48%2,434,207——-30.8%
▸ 9 VERAVera Therapeutics$96.9M5.36%3,000,000——-13.0%
▸ 10 BEAMBeam Therapeutics$96.2M5.33%3,933,894——-14.4%

Pro Feature

The remaining 24 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Kynam Capital Management, LP hold as of Q3 2026?

Kynam Capital Management, LP reported 34 positions worth $1.81B in its Q3 2026 13F filing. Largest positions: LEGN (10.1%), CLDX (9.1%), SNDX (8.5%), PCVX (8.2%) and VRDN (7.0%).

What did Kynam Capital Management, LP buy in Q3 2026?

New positions: SRZN, XENE, EVMN and HROW. Added to: LEGN, SMMT, BEAM, PHVS and COGT (8 in all).

What did Kynam Capital Management, LP sell in Q3 2026?

Reduced: PCVX, RLAY, CLDX, VRDN and CTMX (6 in all). Sold out entirely: INSM and CADL.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.